Warsaw's OrthoPediatrics gains $37 million in funding

WARSAW -- Warsaw-based OrthoPediatrics Corp. has negotiated a $37 million equity investment from Connecticut-based Squadron Capital LLC, its largest shareholder.

The funds will be used to introduce two new products in the scoliosis and sports medicine markets -- the Response Spine System and the OrthoPediatrics Anterior Cruciate Ligament Reconstruction System -- and to increase company employment in Warsaw. The investment also will be used to support OrthoPediatrics' sales growth in 28 countries around the world and to reduce and restructure the debt on the company's balance sheet.